American Association for Cancer Research Annual Meeting

Healio.com brings you the highlights from the American Association for Cancer Research Annual Meeting. Refer back to this page often to read the latest news from AACR, see perspectives and interviews with leading researchers and clinicians, and review archives of past meetings.

Meeting News

Addition of Optune device to temozolomide improves OS in glioblastoma

April 5, 2017
A wearable medical device designed to deliver alternating electrical fields administered in addition to temozolomide chemotherapy improved survival…
Meeting NewsPerspective

Incidence of certain cancers expected to decline among HIV–positive individuals

April 5, 2017
The burden of cancer in HIV–positive patients is projected to decrease by 2030, mostly driven by declines in non-Hodgkin lymphoma and Kaposi…
Meeting NewsPerspective

Atezolizumab prolongs OS for responders with triple-negative breast cancer

April 4, 2017
Patients with triple-negative breast cancer who responded to atezolizumab experienced longer OS than patients who did not respond or used other…
Meeting NewsPerspective

Combined immunotherapy shows early promise in advanced melanoma

April 4, 2017
Patients with advanced melanoma derived benefit from a combination of ipilimumab and Coxsackievirus A21, according to a phase 1b clinical trial…
Meeting NewsPerspective

HER-2targeted therapy effective for treatment-refractory metastatic colorectal cancer

April 4, 2017
The combination of trastuzumab plus lapatinib appeared clinically beneficial for patients with treatment-refractory HER-2positive metastatic…
Meeting NewsPerspective

Nivolumab improves rate of 5-year OS for patients with advanced NSCLC

April 3, 2017
Nivolumab led to a 5-year survival rate much higher than historical rates in patients with advanced non–small cell lung cancer, according to…
Meeting News

Biden: Cancer moonshot has ‘evolved from program to movement’

April 3, 2017
International and private sector collaboration, as well as the $1.8 billion in federal funding directed toward the NIH as part of the 21st Century…
Meeting NewsPerspective

SUMMIT trial ‘guides development’ of pan-HER inhibitor in various cancers

April 3, 2017
Clinical response to neratinib varied by tumor and HER-2 mutation type, according to results from the global, multicenter phase 2 SUMMIT trial…
Meeting News

Racial disparities in QOL correlate with survival in colorectal cancer

April 3, 2017
Patterns of racial disparity in health-related quality of life among patients with colorectal cancer correspond with overall survival, according to…
Meeting News CoverageVideo

VIDEO: I-SPY 2 results suggest potential for new standard in HER-2–positive breast cancer

May 6, 2016
NEW ORLEANS — Hatem Soliman, MD, assistant member of the women’s oncology and breast cancer department at Moffitt Cancer Center, spoke…